Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from PainChek Ltd ( (AU:PCK) ).
PainChek Ltd announced an upcoming investor webinar to discuss their quarterly update and financial performance. The company continues to expand its market presence with its innovative pain assessment technology, which has been adopted by over 1,800 aged care facilities and is being integrated into home care services. This expansion highlights PainChek’s commitment to enhancing pain management practices globally and its potential impact on healthcare providers and patients.
More about PainChek Ltd
PainChek Ltd is a company that specializes in developing smart device-based applications for pain assessment and monitoring. Their primary product, the PainChek app, uses AI technology to automate pain assessment, making it suitable for individuals who cannot reliably self-report their pain. The app is available on smartphones and tablets and has received regulatory clearance in multiple countries, including Australia, Canada, and the European Union. PainChek is widely used in aged care facilities and is expanding into home care services.
YTD Price Performance: 16.67%
Average Trading Volume: 1,100,267
Technical Sentiment Signal: Sell
Current Market Cap: A$64.47M
Learn more about PCK stock on TipRanks’ Stock Analysis page.